SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (17)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Taylor, M. J.
Right arrow Articles by Geddes, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, M. J.
Right arrow Articles by Geddes, J. R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*FLUOXETINE
*TRAZODONE HYDROCHLORIDE
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reviews

Folate for Depressive Disorders: Systematic Review and Meta-Analysis of Randomized Controlled Trials

Matthew J. Taylor

Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK.

Stuart M. Carney

Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK.

Guy M. Goodwin

Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK.

John R. Geddes

Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK., john.geddes{at}psychiatry.ox.ac.uk

The objective of this review was to determine the effectiveness, adverse effects and acceptability of folate in the treatment of depression. Electronic databases (Cochrane Controlled Trials Register and the Cochrane Collaboration Depression, Anxiety and Neurosis Controlled Trials Register) and reference lists were searched, and authors, experts and pharmaceutical companies contacted to identify randomized controlled trials that compared treatment with folic acid or 5 '-methyltetrahydrofolic acid to an alternative treatment, for patients with a diagnosis of depressive disorder. Three randomized trials (247 participants) were included. Two studies assessed the use of folate in addition to other treatment, and found that adding folate reduced Hamilton Depression Rating Scale (HDRS) scores on average by a further 2.65 points [95% confidence interval (CI) 0.38-4.93]. Fewer patients treated with folate experienced a reduction in their HDRS score of less than 50% at 10 weeks (relative risk 0.47, 95% CI 0.24-0.92). The remaining study found no statistically significant difference when folate alone was compared with trazodone. The identified trials did not find evidence of any problems with the acceptability or safety of folate. The limited available evidence suggests folate may have a potential role as a supplement to other treatment for depression. It is currently unclear if this is the case both for people with normal folate levels, and for those with folate deficiency.

Key Words: 5-methyltetrahydrofolate • depressive disorder • folic acid • meta-analysis • review

Journal of Psychopharmacology, Vol. 18, No. 2, 251-256 (2004)
DOI: 10.1177/0269881104042630


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
M. Chung, E. M Balk, S. Ip, G. Raman, W. W Yu, T. A Trikalinos, A. H Lichtenstein, E. A Yetley, and J. Lau
Reporting of systematic reviews of micronutrients and health: a critical appraisal
Am. J. Clinical Nutrition, April 1, 2009; 89(4): 1099 - 1113.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
O. P. Almeida, K. McCaul, G. J. Hankey, P. Norman, K. Jamrozik, and L. Flicker
Homocysteine and Depression in Later Life
Arch Gen Psychiatry, November 1, 2008; 65(11): 1286 - 1294.
[Abstract] [Full Text] [PDF]


Home page
Journal of Pharmacy PracticeHome page
T. S. Hunter
L-methylfolate in the Therapeutic Management of Major Depressive Disorder
Journal of Pharmacy Practice, August 1, 2008; 21(4): 278 - 286.
[Abstract] [PDF]


Home page
Am. J. PsychiatryHome page
M. Folstein, T. Liu, I. Peter, J. Buel, L. Arsenault, T. Scott, and W. W. Qiu
The Homocysteine Hypothesis of Depression
Am J Psychiatry, June 1, 2007; 164(6): 861 - 867.
[Abstract] [Full Text] [PDF]


Home page
FocusHome page
A. A. Nierenberg, P. Eidelman, Y. Wu, and M. Joseph
Depression: An Update for the Clinician
Focus, January 1, 2005; 3(1): 3 - 12.
[Full Text] [PDF]


Home page
J PsychopharmacolHome page
A. Coppen and C. Bolander-Gouaille
Treatment of depression: time to consider folic acid and vitamin B12
J Psychopharmacol, January 1, 2005; 19(1): 59 - 65.
[Abstract] [PDF]



Advertisement